Sign up to save your podcasts
Or
Share Mel Gibson's Passion Sequel: Recasting Jesus, Ivermectin Claims, and Legacy Risks
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Mel Gibson's Passion Sequel: Recasting Jesus, Ivermectin Claims, and Legacy Risks
Mel Gibson BioSnap a weekly updated Biography.
Mel Gibson has dominated headlines this past week with news swirling around his highly anticipated sequel to The Passion of the Christ. Industry insiders broke the story that Gibson has officially recast the role of Jesus, once played by Jim Caviezel, for The Resurrection of the Christ, a two-part sequel set for theatrical release in 2027 with the first installment premiering on Good Friday. This pivot marks one of the most consequential shifts for a project that has been gestating for years. Caviezel’s absence has ignited intense fan reaction across social media, with Twitter and Facebook users lamenting his departure and questioning the creative direction while prominent outlets like AOL and Radar Online have dubbed the recasting “blasphemous” and a risk for the franchise’s legacy.
Gibson himself has been notably visible in Italy prepping the shoot. Variety reported that Gibson met with Italy’s Culture Minister Alessandro Giuli in Matera, exchanging pleasantries and posing for photos as production ramps up at Cinecittà Studios. Sources from Il Messaggero revealed additional controversy over Gibson’s casting of Polish actress Kasia Smutniak as Mary Magdalene, with groups of Polish Catholics decrying the move and labeling the project as provocative.
Business activity around the film is accelerating, with Gibson’s Icon Productions partnering with Lionsgate and leveraging Italy’s UNESCO heritage sites for principal photography. This blockbuster sequel could reshape Gibson’s legacy in both Hollywood and faith-based cinema circles given that the original Passion grossed over $600 million and remains a cultural flashpoint.
Outside of cinema, Gibson recently appeared on The Joe Rogan Experience podcast. He recounted harrowing anecdotes from his career, even revealing he nearly died on the set of Braveheart—one accident involving a horse and another mishap where he accidentally hanged himself trying to stage a scene. During the same podcast, Gibson’s remarks about ivermectin—claiming it cured several friends’ stage four cancer—became a catalyst for Florida’s controversial $60 million cancer research push using the drug. The Times of India and Canadian Cancer Society blasted Gibson, warning that such celebrity-driven health claims were “dangerous, cruel, and irresponsible.”
On social media channels and faith-based YouTube accounts, Gibson’s spiritual journey remains an active topic, with videos like “Mel Gibson Finally Breaks His Silence” chronicling his reflections on the original Passion shoot, mysterious setbacks, and the transformation that has shaped his work and worldview. Though Gibson continues to dodge long interviews and behind-the-scenes documentaries, the mystery and drama swirling around his latest moves ensure he stays at the center of public conversation—both for his art and his controversies.
Get the best deals https://amzn.to/3ODvOta
This content was created in partnership and with the help of Artificial Intelligence AI
Mel Gibson has dominated headlines this past week with news swirling around his highly anticipated sequel to The Passion of the Christ. Industry insiders broke the story that Gibson has officially recast the role of Jesus, once played by Jim Caviezel, for The Resurrection of the Christ, a two-part sequel set for theatrical release in 2027 with the first installment premiering on Good Friday. This pivot marks one of the most consequential shifts for a project that has been gestating for years. Caviezel’s absence has ignited intense fan reaction across social media, with Twitter and Facebook users lamenting his departure and questioning the creative direction while prominent outlets like AOL and Radar Online have dubbed the recasting “blasphemous” and a risk for the franchise’s legacy.
Gibson himself has been notably visible in Italy prepping the shoot. Variety reported that Gibson met with Italy’s Culture Minister Alessandro Giuli in Matera, exchanging pleasantries and posing for photos as production ramps up at Cinecittà Studios. Sources from Il Messaggero revealed additional controversy over Gibson’s casting of Polish actress Kasia Smutniak as Mary Magdalene, with groups of Polish Catholics decrying the move and labeling the project as provocative.
Business activity around the film is accelerating, with Gibson’s Icon Productions partnering with Lionsgate and leveraging Italy’s UNESCO heritage sites for principal photography. This blockbuster sequel could reshape Gibson’s legacy in both Hollywood and faith-based cinema circles given that the original Passion grossed over $600 million and remains a cultural flashpoint.
Outside of cinema, Gibson recently appeared on The Joe Rogan Experience podcast. He recounted harrowing anecdotes from his career, even revealing he nearly died on the set of Braveheart—one accident involving a horse and another mishap where he accidentally hanged himself trying to stage a scene. During the same podcast, Gibson’s remarks about ivermectin—claiming it cured several friends’ stage four cancer—became a catalyst for Florida’s controversial $60 million cancer research push using the drug. The Times of India and Canadian Cancer Society blasted Gibson, warning that such celebrity-driven health claims were “dangerous, cruel, and irresponsible.”
On social media channels and faith-based YouTube accounts, Gibson’s spiritual journey remains an active topic, with videos like “Mel Gibson Finally Breaks His Silence” chronicling his reflections on the original Passion shoot, mysterious setbacks, and the transformation that has shaped his work and worldview. Though Gibson continues to dodge long interviews and behind-the-scenes documentaries, the mystery and drama swirling around his latest moves ensure he stays at the center of public conversation—both for his art and his controversies.
Get the best deals https://amzn.to/3ODvOta
This content was created in partnership and with the help of Artificial Intelligence AI
View all episodes
By Inception Point AiMel Gibson BioSnap a weekly updated Biography.
Mel Gibson has dominated headlines this past week with news swirling around his highly anticipated sequel to The Passion of the Christ. Industry insiders broke the story that Gibson has officially recast the role of Jesus, once played by Jim Caviezel, for The Resurrection of the Christ, a two-part sequel set for theatrical release in 2027 with the first installment premiering on Good Friday. This pivot marks one of the most consequential shifts for a project that has been gestating for years. Caviezel’s absence has ignited intense fan reaction across social media, with Twitter and Facebook users lamenting his departure and questioning the creative direction while prominent outlets like AOL and Radar Online have dubbed the recasting “blasphemous” and a risk for the franchise’s legacy.
Gibson himself has been notably visible in Italy prepping the shoot. Variety reported that Gibson met with Italy’s Culture Minister Alessandro Giuli in Matera, exchanging pleasantries and posing for photos as production ramps up at Cinecittà Studios. Sources from Il Messaggero revealed additional controversy over Gibson’s casting of Polish actress Kasia Smutniak as Mary Magdalene, with groups of Polish Catholics decrying the move and labeling the project as provocative.
Business activity around the film is accelerating, with Gibson’s Icon Productions partnering with Lionsgate and leveraging Italy’s UNESCO heritage sites for principal photography. This blockbuster sequel could reshape Gibson’s legacy in both Hollywood and faith-based cinema circles given that the original Passion grossed over $600 million and remains a cultural flashpoint.
Outside of cinema, Gibson recently appeared on The Joe Rogan Experience podcast. He recounted harrowing anecdotes from his career, even revealing he nearly died on the set of Braveheart—one accident involving a horse and another mishap where he accidentally hanged himself trying to stage a scene. During the same podcast, Gibson’s remarks about ivermectin—claiming it cured several friends’ stage four cancer—became a catalyst for Florida’s controversial $60 million cancer research push using the drug. The Times of India and Canadian Cancer Society blasted Gibson, warning that such celebrity-driven health claims were “dangerous, cruel, and irresponsible.”
On social media channels and faith-based YouTube accounts, Gibson’s spiritual journey remains an active topic, with videos like “Mel Gibson Finally Breaks His Silence” chronicling his reflections on the original Passion shoot, mysterious setbacks, and the transformation that has shaped his work and worldview. Though Gibson continues to dodge long interviews and behind-the-scenes documentaries, the mystery and drama swirling around his latest moves ensure he stays at the center of public conversation—both for his art and his controversies.
Get the best deals https://amzn.to/3ODvOta
This content was created in partnership and with the help of Artificial Intelligence AI
Mel Gibson has dominated headlines this past week with news swirling around his highly anticipated sequel to The Passion of the Christ. Industry insiders broke the story that Gibson has officially recast the role of Jesus, once played by Jim Caviezel, for The Resurrection of the Christ, a two-part sequel set for theatrical release in 2027 with the first installment premiering on Good Friday. This pivot marks one of the most consequential shifts for a project that has been gestating for years. Caviezel’s absence has ignited intense fan reaction across social media, with Twitter and Facebook users lamenting his departure and questioning the creative direction while prominent outlets like AOL and Radar Online have dubbed the recasting “blasphemous” and a risk for the franchise’s legacy.
Gibson himself has been notably visible in Italy prepping the shoot. Variety reported that Gibson met with Italy’s Culture Minister Alessandro Giuli in Matera, exchanging pleasantries and posing for photos as production ramps up at Cinecittà Studios. Sources from Il Messaggero revealed additional controversy over Gibson’s casting of Polish actress Kasia Smutniak as Mary Magdalene, with groups of Polish Catholics decrying the move and labeling the project as provocative.
Business activity around the film is accelerating, with Gibson’s Icon Productions partnering with Lionsgate and leveraging Italy’s UNESCO heritage sites for principal photography. This blockbuster sequel could reshape Gibson’s legacy in both Hollywood and faith-based cinema circles given that the original Passion grossed over $600 million and remains a cultural flashpoint.
Outside of cinema, Gibson recently appeared on The Joe Rogan Experience podcast. He recounted harrowing anecdotes from his career, even revealing he nearly died on the set of Braveheart—one accident involving a horse and another mishap where he accidentally hanged himself trying to stage a scene. During the same podcast, Gibson’s remarks about ivermectin—claiming it cured several friends’ stage four cancer—became a catalyst for Florida’s controversial $60 million cancer research push using the drug. The Times of India and Canadian Cancer Society blasted Gibson, warning that such celebrity-driven health claims were “dangerous, cruel, and irresponsible.”
On social media channels and faith-based YouTube accounts, Gibson’s spiritual journey remains an active topic, with videos like “Mel Gibson Finally Breaks His Silence” chronicling his reflections on the original Passion shoot, mysterious setbacks, and the transformation that has shaped his work and worldview. Though Gibson continues to dodge long interviews and behind-the-scenes documentaries, the mystery and drama swirling around his latest moves ensure he stays at the center of public conversation—both for his art and his controversies.
Get the best deals https://amzn.to/3ODvOta
This content was created in partnership and with the help of Artificial Intelligence AI